Odyssey Therapeutics, Inc. (ODTX) Financials
ODTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 483.9 million | 62.6 million |
| March 31, 2026 | 229.1 million | 752.8 million |
| June 30, 2025 | ? | ? |
| March 31, 2025 | ? | ? |
ODTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -34.7 million | 5.7 million |
| March 31, 2026 | -41.2 million | 2.6 million |
| June 30, 2025 | -34.3 million | 3.7 million |
| March 31, 2025 | -39.5 million | 3.0 million |
ODTX Net Income
No data available :(
ODTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | - | - | 24.8 million |
| March 31, 2026 | 175.7 million | - | 26.1 million |
| June 30, 2025 | - | - | - |
| March 31, 2025 | - | - | - |
ODTX Shares Outstanding
ODTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 186000 | 36.2 million | 10.5 million | - |
| March 31, 2026 | 148000 | 32.3 million | 7.4 million | - |
| June 30, 2025 | 29000 | 30.2 million | 13.2 million | - |
| March 31, 2025 | 927000 | 38.8 million | 8.0 million | - |
ODTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| June 30, 2025 | 959000 | - |
| March 31, 2025 | 1.9 million | - |
ODTX
Price: $24.67
52 week price:
Earnings Per Share: -3.52 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.0 billion